Who
Gregory D. Wasson
Director
Company insider
Files Form 4 as: Director, OptimizeRx; Director and 10% owner, P3 Health Partners; Director, PNC Financial Services Group; Director, Verizon Communications; President and CEO, Walgreen Co.
In numbers
- Trades disclosed
- 109
- Buys
- 2
- Sells
- 4
- Bought
- $262K
- Sold
- $3.5M
- Companies
- 5
- Companies where not an officer
- 4
- First trade
- 11 Apr 2006
- Last trade
- 9 Jun 2026
- Last filed
- 10 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Jun 2026filed 10 Jun 2026 | OPRX OptimizeRxBusiness Services | SEC FORM 4 Code A | —34,517 at $0.00 | filing |
| 9 Jun 2026filed 10 Jun 2026 | OPRX OptimizeRxBusiness Services | SEC FORM 4 Code A | —34,517 at $0.00 | filing |
| 6 Aug 2025filed 23 Jan 2026 | PIII P3 Health PartnersProviders & Facilities | SEC FORM 4 Code A | —2,000 at $0.00 | filing |
| 6 Aug 2025filed 23 Jan 2026 | PIII P3 Health PartnersProviders & Facilities | SEC FORM 4 Code A | —2,000 at $0.00 | filing |
| 6 Aug 2025filed 8 Aug 2025 | PIII P3 Health PartnersProviders & Facilities | SEC FORM 4 Code A | —2,000 at $0.00 | filing |
| 11 Jun 2025filed 12 Jun 2025 | OPRX OptimizeRxBusiness Services | SEC FORM 4 Code A | —9,868 at $0.00 | filing |
| 7 Jun 2024filed 11 Jun 2024 | OPRX OptimizeRxBusiness Services | SEC FORM 4 Code A | —13,286 at $0.00 | filing |
| 6 Jun 2024filed 10 Jun 2024 | PIII P3 Health Partnersoption or derivative · Providers & Facilities | SEC FORM 4 Code A | —482,640 at $0.00 | filing |
| 5 Jun 2024filed 11 Jun 2024 | OPRX OptimizeRxoption or derivative · Business Services | SEC FORM 4 Code M | —10,061 at $0.00 | filing |
| 5 Jun 2024filed 11 Jun 2024 | OPRX OptimizeRxBusiness Services | SEC FORM 4 Code M | —10,061 at $0.00 | filing |
| 23 Oct 2023filed 25 Jan 2024 | PIII P3 Health PartnersProviders & Facilities | SEC FORM 4 Code A | —216,561 at $0.00 | filing |
| 7 Jun 2023filed 18 Aug 2023 | OPRX OptimizeRxoption or derivative · Business Services | SEC FORM 4 Code M | —4,637 at $0.00 | filing |
| 7 Jun 2023filed 18 Aug 2023 | OPRX OptimizeRxoption or derivative · Business Services | SEC FORM 4 Code A | —10,061 at $0.00 | filing |
| 7 Jun 2023filed 18 Aug 2023 | OPRX OptimizeRxBusiness Services | SEC FORM 4 Code M | —4,637 at $0.00 | filing |
| 31 Mar 2023filed 3 Apr 2023 | OPRX OptimizeRxoption or derivative · Business Services | SEC FORM 4 Code M | —657 at $0.00 | filing |
| 31 Mar 2023filed 3 Apr 2023 | OPRX OptimizeRxBusiness Services | SEC FORM 4 Code M | —657 at $0.00 | filing |
| 30 Dec 2022filed 4 Jan 2023 | OPRX OptimizeRxoption or derivative · Business Services | SEC FORM 4 Code M | —409 at $0.00 | filing |
| 30 Dec 2022filed 4 Jan 2023 | OPRX OptimizeRxBusiness Services | SEC FORM 4 Code M | —409 at $0.00 | filing |
| 29 Sep 2022filed 30 Sep 2022 | OPRX OptimizeRxoption or derivative · Business Services | SEC FORM 4 Code M | —334 at $0.00 | filing |
| 29 Sep 2022filed 30 Sep 2022 | OPRX OptimizeRxBusiness Services | SEC FORM 4 Code M | —334 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.